3:36 PM Abstract No. 265 Safety and feasibility of integrating yttrium-90 radioembolization with capecitabine-temozolomide for grade 2 liver-dominant metastatic neuroendocrine tumors (CapTemY90): final report

Journal of Vascular and Interventional Radiology(2018)

引用 0|浏览19
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要